Implementation and outcomes of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) monoclonal antibody treatment program at an academic medical center serving a high-risk patient population
Saved in:
Main Authors: | Scott A. Borgetti (Author), Alan E. Gross (Author), Janey Kottler (Author), Kenil Patel (Author), Jamie Paek (Author), Alfredo J. Mena Lora (Author), Diane Oikle (Author), Delisa Jeffries (Author), Jon Radosta (Author) |
---|---|
Format: | Book |
Published: |
Cambridge University Press,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Remdesivir use and antimicrobial stewardship restrictions during the coronavirus disease 2019 (COVID-19) pandemic in the United States: A cross-sectional survey
by: Alfredo J. Mena Lora, et al.
Published: (2023) -
Evaluation of the accuracy of a mandatory indication field for outpatient antibiotic prescriptions
by: Johanna Papanikolla, et al.
Published: (2023) -
Monoclonal antibodies for coronavirus infection in pregnant and puerperal women
by: O.V. Polikarpova, et al.
Published: (2023) -
Antimicrobial stewardship and drug formulary restrictions during COVID-19: what is restricted and who decides?
by: Alfredo J. Mena Lora, et al.
Published: (2023) -
Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa before and after the coronavirus disease 2019 (COVID-19) pandemic in the Dominican Republic
by: Alfredo J. Mena Lora, et al.
Published: (2022)